Shandong Xinhua Pharmaceutical Company Limited announced that Mr. Chan Chung Kik, Lewis' tendering of resignation on 25 April 2018 from his offices of an independent non-executive Director, the chairman of the Audit Committee and a member of the Remuneration and Examination Committee of the Board to take effect from the assumption of office by a new independent non-executive Director in his replacement, the board has on 16 May 2018 resolved to nominate Mr. Lo Wah Wai, a practicing member of the Hong Kong Institute of Certified Public Accountants and a member of the American Institute of Certified Public Accountants, as an independent non-executive Director candidate for a term concurrent with the ninth session of the Board until 22 December 2020 to fill the upcoming vacancy resulting from the Resignation. The appointment of Mr. Lo is subject to and shall take effect from the approval of the Shareholders by way of ordinary resolution at the AGM. Subject to the aforementioned, Mr. Lo will be appointed as the Chairman of the Audit Committee, a member of the Remuneration and Examination Committee and a member of the Nomination Committee of the Board.